|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q2 FY2017
As of Jun 30, 2017
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES & STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Contingent liability - legal | ||||||||||||||||||||
| Contingent liability - notes | ||||||||||||||||||||
| Derivative liability - warrants | ||||||||||||||||||||
| Notes payable – related parties | ||||||||||||||||||||
| Derivative liability - convertible notes | ||||||||||||||||||||
| Convertible notes - related parties | ||||||||||||||||||||
| Convertible notes | ||||||||||||||||||||
| Notes payable - related parties | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock (Series B), $0.001 par value, 51 shares authorized, and 51 shares issued and outstanding, on September 30, 2021, and December 31, 2020, respectively | ||||||||||||||||||||
| Common stock, $0.00001 par value, 500,000,000 shares authorized, 353,524,425 and 285,555,605 shares issued and outstanding on September 30, 2021, and December 31, 2020, respectively | ||||||||||||||||||||
| Paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' (Deficit) | ||||||||||||||||||||
| Total Liabilities and Stockholders' (Equity) | ||||||||||||||||||||
Loading...
